The Board of Directors of the Company has appointed Austen B. Helfrich to serve as the Company’s Interim Chief Financial Officer effective October 1, 2024.
Departed
J. Christopher Douglas
Executive Vice President and Chief Financial Officer
On September 10, 2024, Healthcare Realty Trust Incorporated (the “Company”) and J. Christopher Douglas determined that Mr. Douglas would depart from his position as Executive Vice President and Chief Financial Officer of the Company, effective October 1, 2024.
Matthew T. Farrell, Chairman and Chief Executive Officer of Church & Dwight Co., Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) that he will retire as President and Chief Executive Officer, effective as of March 31, 2025.
appointed Warner Biddle as the Company’s Chief Executive Officer and as a Class III director of the Company, in each case effective September 16, 2024
Appointed
Joseph Matozzo
Chief Executive Officer
U.S. Lighting Group, Inc.
Effective
2024-09-06
Filed
September 16, 2024, 7:59 PM ET
On September 6, 2024, the board of directors of US Lighting Group, Inc. (the “Company”) appointed Joseph Matozzo (“Mr. Matozzo”) as chief executive officer of the Company.
Effective September 16, 2024, Ms. Yuanmei Ma will resign from her positions as Chief Financial Officer and member of the Board of Directors of the Company.
On September 16, 2024, Lattice Semiconductor Corporation (the “Company”) announced the appointment of Ford Tamer as President and Chief Executive Officer (“CEO”) of the Company, effective September 16, 2024 (the “Start Date”).
Departed
John North
Chief Executive Officer and Director
Lazydays Holdings, Inc.
Effective
2024-09-13
Successor
Ronald Fleming
Filed
September 16, 2024, 7:59 PM ET
On September 13, 2024, John North resigned as Chief Executive Officer of Lazydays Holdings, Inc., a Delaware corporation (the “ Company ”), and as a director of the Company.
Appointed
(interim)
Ronald Fleming
Interim Chief Executive Officer and Director
Lazydays Holdings, Inc.
Effective
2024-09-14
Filed
September 16, 2024, 7:59 PM ET
On September 13, 2024, the Company’s board of directors (the “ Board ”) appointed Ronald Fleming, age 65, as Interim Chief Executive Officer of the Company and as a director of the Company, effective September 14, 2024.
Appointed
(interim)
Kaile A. Zagger
Interim Chief Executive Officer and Chief Restructuring Officer
Notable Labs, Ltd.
Effective
2024-09-16
Filed
September 16, 2024, 7:59 PM ET
On September 16, 2024, Notable Labs, Ltd. (the “Company” or “Notable”) appointed Kaile A. Zagger as its Interim Chief Executive Officer and Chief Restructuring Officer.
On September 10, 2024, Jeremy Whitaker informed Lantronix, Inc. (the “Company”) that he was resigning as the Company’s Chief Financial Officer effective September 13, 2024.
Appointed
(interim)
Brent Stringham
Chief Accounting Officer and Chief Financial Officer
On September 14, 2024, the Company’s Board of Directors (the “Board”) appointed Brent Stringham as the Company’s Chief Accounting Officer and Chief Financial Officer.
the Board appointed the Board’s current Chairman and Executive Chair, Mr. David Buzby, age 64, as the Company’s interim Chief Executive Officer (“Interim CEO”), effective September 11, 2024.
Mr. John Carrington stepped down as Chief Executive Officer of the Company and as a member of the Company’s board of directors (the “Board”), effective September 11, 2024.
On September 12, 2024, Kimberly Bambach tendered her resignation from her role as interim Chief Financial Officer of the Company, effective October 1, 2024.
Appointed
(interim)
Lisa Wolf
interim Chief Financial Officer and Principal Financial and Principal Accounting Officer
Effective October 1, 2024, Lisa Wolf has been appointed as the Company’s new interim Chief Financial Officer and Principal Financial and Principal Accounting Officer.
Appointed
(interim)
Brian Chesnut
interim Chief Financial Officer
DZS INC.
Effective
2024-09-11
Filed
September 13, 2024, 7:59 PM ET
The Board of Directors (the “Board”) of DZS Inc. (the “Company”) elected Brian Chesnut to serve as the Company’s interim Chief Financial Officer.
Departed
Misty Kawecki
Chief Financial Officer
DZS INC.
Effective
2024-09-11
Successor
Brian Chesnut
Filed
September 13, 2024, 7:59 PM ET
The Board removed Misty Kawecki as the Company’s Chief Financial Officer at such time.
Role change
Jeffrey D. Creech
Executive Vice President and Chief Financial Officer and Principal Accounting Officer
Effective September 9, 2024, Jeffrey D. Creech, our current Executive Vice President and Chief Financial Officer, assumed the role of principal accounting officer.
On September 12, 2024, the Board of Directors (the “Board”) of the Company approved the appointment of Alexander Epshinsky as the Chief Financial Officer of the Company as of September 12, 2024, succeeding Ms. Brown.
Departed
Ryan Maarschalk
Chief Financial Officer
Allied Corp.
Effective
2024-08-19
Filed
September 13, 2024, 7:59 PM ET
On August 21, 2024, effective August 19, 2024, the Company and Ryan Maarschalk entered into a Termination Agreement pursuant to which Mr. Maarschalk ceased to be Chief Financial Officer of the Company.
appointed Neil Barua, the Company’s existing Chief Executive Officer, to the dual positions of President and Chief Executive Officer of the Company effective as of October 1, 2024.
On September 11, 2024, the Board of Directors of PetMed Express, Inc. (“Company”) appointed Robyn D’Elia to serve as the Company’s Chief Financial Officer and to assume the duties of principal financial officer effective September 16, 2024 (“Effective Date”).
terminated Alan H. Shaw, President and Chief Executive Officer of the Company, in connection with preliminary findings from an ongoing investigation conducted by independent counsel that determined Shaw violated Company policies by engaging in a consensual relationship with the Company’s Chief Legal Officer.
Mark R. George, the current Executive Vice President and Chief Financial Officer of the Company, has been appointed as President and Chief Executive Officer of the Company, as a member of the Board and as a member of the Executive Committee of the Board, effective immediately.
Jason A. Zampi, the current Senior Vice President Finance & Treasurer, is being appointed as the Acting Chief Financial Officer of the Company, effective immediately.
Departed
Olivier Thirot
Executive Vice President and Chief Financial Officer
On September 12, 2024, Kelly Services, Inc. (the “Company”) announced that Troy R. Anderson has been named Executive Vice President and Chief Financial Officer designate, with a target start date of October 14, 2024.
Departed
Nathan Hardy
Executive Vice President and Chief Financial Officer
On September 6, 2024, Nathan Hardy notified Sana Biotechnology, Inc. (the “Company”) that he intends to resign from his position as Executive Vice President and Chief Financial Officer of the Company effective October 4, 2024.
Pursuant to the Settlement Agreement, Mr. Khurshid advised the Company that he was resigning as Chief Executive Officer and as a director of the Company effective September 4, 2024.
On September 10, 2024, Mr. Ozan Pamir, the Chief Financial Officer (Principal Financial/Accounting Officer) and Secretary of 180 Life Sciences Corp. (the “Company ", “we” and “us”), tendered his resignation to the board of directors of the Company (the “Board”), effective September 30, 2024.
On September 11, 2024, the Board resolved to appoint Mr. Omar Jimenez, a current member of the Board, as Chief Financial Officer (Principal Financial/Accounting Officer) and Secretary, to fill the vacancy left by Mr. Pamir’s departure, effective on September 30, 2024.
On September 8, 2024, the Board of Directors (the “Board”) of Serina Therapeutics, Inc. (the “Company”) appointed Steven Ledger, the current Interim Chief Executive Officer of the Company, to be the Company’s Chief Executive Officer.
On and effective September 11, 2024, the Board of Directors (the “Board”) of Tilly’s, Inc. (the “Company”) appointed Hezy Shaked, the Company’s co-founder and Executive Chairman of the Board, as the Company’s President and Chief Executive Officer.
the Board of Directors (the “Board”) of Open Lending Corporation (the “Company”) announced that it has appointed Charles D. Jehl as the Chief Executive Officer of the Company on a permanent, non-interim basis and elected Mr. Jehl as a member of the Board, each effective as of the same date.
On September 5, 2024, the Board of Directors (the “Board”) of SentinelOne, Inc. (the “Company”) appointed Barbara Larson as the Company’s Chief Financial Officer and principal financial officer, effective as of September 11, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.